External Factors Modulating Pain and Pain-Related Functional Impairment in Cervical Dystonia.
Pain in Dystonia Scale (PIDS)
cervical dystonia
external factors
pain
relieving factors
trigger
Journal
Movement disorders clinical practice
ISSN: 2330-1619
Titre abrégé: Mov Disord Clin Pract
Pays: United States
ID NLM: 101630279
Informations de publication
Date de publication:
23 Oct 2024
23 Oct 2024
Historique:
revised:
09
09
2024
received:
03
07
2024
accepted:
04
10
2024
medline:
23
10
2024
pubmed:
23
10
2024
entrez:
23
10
2024
Statut:
aheadofprint
Résumé
Little is known about factors modulating pain and pain-related functional impairment in isolated cervical dystonia (CD). The aim was to assess the prevalence and interrelationship between pain-modulating factors and pain-related determinants of functional impairment and quality of life in CD. We analyzed pain-aggravating and pain-relieving external factors, the degree of pain-related functional impact on routine activities, and the relationship between these and pain severity, using cross-sectional data collected using the Pain in Dystonia Scale (PIDS) from 85 participants with CD. Pairwise correlation analyses and age- and sex-adjusted linear regression models estimated the relationship between pain-modulating factors and pain severity, and the impact of pain severity, dystonia severity, and psychiatric symptoms on pain-related functional impairment and disease-specific quality of life (measured using the Craniocervical Dystonia Questionnaire-24). Stress and prolonged fixed position were the most frequent and impacting pain triggers, with women reporting larger impact. The average impact of pain-relieving factors was lower than that of pain triggers. Physical exercise and social gatherings were the most impacted activities by pain in CD. The intensity of external modulating factors was a predictor of pain severity. Severity of pain, CD, and psychiatric symptoms independently predicted pain-related functional impairment, whereas quality of life was predicted by pain severity, pain-related functional impairment, and psychiatric symptom severity, but not dystonia severity. The PIDS provides insight into external modulation and functional impact of pain in CD. The pattern of external modulation of pain in CD is in line with a multifactorial modulation and complex physiology.
Sections du résumé
BACKGROUND
BACKGROUND
Little is known about factors modulating pain and pain-related functional impairment in isolated cervical dystonia (CD).
OBJECTIVE
OBJECTIVE
The aim was to assess the prevalence and interrelationship between pain-modulating factors and pain-related determinants of functional impairment and quality of life in CD.
METHODS
METHODS
We analyzed pain-aggravating and pain-relieving external factors, the degree of pain-related functional impact on routine activities, and the relationship between these and pain severity, using cross-sectional data collected using the Pain in Dystonia Scale (PIDS) from 85 participants with CD. Pairwise correlation analyses and age- and sex-adjusted linear regression models estimated the relationship between pain-modulating factors and pain severity, and the impact of pain severity, dystonia severity, and psychiatric symptoms on pain-related functional impairment and disease-specific quality of life (measured using the Craniocervical Dystonia Questionnaire-24).
RESULTS
RESULTS
Stress and prolonged fixed position were the most frequent and impacting pain triggers, with women reporting larger impact. The average impact of pain-relieving factors was lower than that of pain triggers. Physical exercise and social gatherings were the most impacted activities by pain in CD. The intensity of external modulating factors was a predictor of pain severity. Severity of pain, CD, and psychiatric symptoms independently predicted pain-related functional impairment, whereas quality of life was predicted by pain severity, pain-related functional impairment, and psychiatric symptom severity, but not dystonia severity.
CONCLUSION
CONCLUSIONS
The PIDS provides insight into external modulation and functional impact of pain in CD. The pattern of external modulation of pain in CD is in line with a multifactorial modulation and complex physiology.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ipsen Pharmaceuticals
Informations de copyright
© 2024 The Author(s). Movement Disorders Clinical Practice published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Références
Peall KJ, Berman BD, Bruggemann N, et al. Non‐motor symptoms in dystonia: from diagnosis to treatment. Dystonia 2023;2:11860. https://doi.org/10.3389/dyst.2023.11860.
Junker J, Hall J, Berman BD, et al. Longitudinal predictors of health‐related quality of life in isolated dystonia. J Neurol 2024;271(2):852–863. https://doi.org/10.1007/s00415-023-12022-4.
Avenali M, De Icco R, Tinazzi M, Defazio G, Tronconi L, Sandrini G, Tassorelli C. Pain in focal dystonias‐a focused review to address an important component of the disease. Parkinsonism Relat Disord 2018;54:17–24. https://doi.org/10.1016/j.parkreldis.2018.04.030.
Tinazzi M, Erro R, Mascia MM, et al. Demographic and clinical determinants of neck pain in idiopathic cervical dystonia. J Neural Transm (Vienna) 2020;127(10):1435–1439. https://doi.org/10.1007/s00702-020-02245-4.
Junker J, Berman BD, Hall J, et al. Quality of life in isolated dystonia: non‐motor manifestations matter. J Neurol Neurosurg Psychiatry 2021;92(6):622–628. https://doi.org/10.1136/jnnp-2020-325193.
Maione R, Formica C, Quartarone A, Lo BV. The impact of non‐motor symptoms on quality of life in cervical dystonia. J Clin Med 2023;12(14):4663. https://doi.org/10.3390/jcm12144663.
Zolin A, Broner SW, Yoo A, et al. Dystonia phenomenology and treatment response in migraine. Headache 2023;63(2):255–263. https://doi.org/10.1111/head.14467.
Barbanti P, Fabbrini G, Pauletti C, Defazio G, Cruccu G, Berardelli A. Headache in cranial and cervical dystonia. Neurology 2005;64(7):1308–1309.
Martino D, Defazio G, Alessio G, et al. Relationship between eye symptoms and blepharospasm: a multicenter case‐control study. Mov Disord 2005;20(12):1564–1570. https://doi.org/10.1002/mds.20635.
Scorr LM, Cho HJ, Kilic‐Berkmen G, et al. Clinical features and evolution of Blepharospasm: a multicenter international cohort and systematic literature review. Dystonia 2022;1:10359. https://doi.org/10.3389/dyst.2022.10359.
Yoshida K. Effects of botulinum toxin type a on pain among trigeminal neuralgia, myofascial temporomandibular disorders, and Oromandibular dystonia. Toxins (Basel) 2021;13(9):605. https://doi.org/10.3390/toxins13090605.
Pérez‐de‐Heredia‐Torres M, García‐Bravo C, Huertas‐Hoyas E, Martínez‐Piédrola MR, Serrada‐Tejeda S, Martínez‐Castrillo JC. Sensitivity and pain in focal dystonia of the hand. Neurologia (Engl Ed) 2022;37(9):711–716. https://doi.org/10.1016/j.nrleng.2019.12.005.
Vilaseca I, Hidalgo J, Cámara A, Compta Y, Martí MJ. Non‐motor symptoms in spasmodic dysphonia: a case control‐study. Auris Nasus Larynx 2022;49(1):100–105. https://doi.org/10.1016/j.anl.2021.05.004.
Crisafulli O, Ravizzotti E, Mezzarobba S, et al. A gait‐based paradigm to investigate central body representation in cervical dystonia patients. Neurol Sci 2023;44(4):1311–1318. https://doi.org/10.1007/s10072-022-06548-0.
Di Biasio F, Marchese R, Abbruzzese G, et al. Motor and sensory features of cervical dystonia subtypes: data from the Italian dystonia registry. Front Neurol 2020;26(11):906. https://doi.org/10.3389/fneur.2020.00906.
Cotton AC, Scorr L, McDonald W, et al. Assessing the severity of cervical dystonia: ask the doctor or ask the patient? Mov Disord Clin Pract 2023;10(9):1399–1403. https://doi.org/10.1002/mdc3.13827.
Albanese A, Wissel J, Jost WH, et al. Pain reduction in cervical dystonia following treatment with IncobotulinumtoxinA: a pooled analysis. Toxins (Basel). 2023;15(5):333. https://doi.org/10.3390/toxins15050333.
Jankovic J, Tsui J, Brin MF. Treatment of cervical dystonia with Botox (onabotulinumtoxinA): development, insights, and impact. Medicine (Baltimore) 2023;102(S1):e32403. https://doi.org/10.1097/MD.0000000000032403.
Khanom AA, Franceschini PR, Lane S, Osman‐Farah J, Macerollo A. Bilateral globus pallidus internus (GPi) deep brain stimulation for cervical dystonia: effects on motor and non‐motor symptoms within 5 years follow. J Neurol Sci 2023;452:120752. https://doi.org/10.1016/j.jns.2023.120752.
Marciniec M, Szczepańska‐Szerej A, Papuć E, Rejdak K. Targeting pain in the long‐term treatment of cervical dystonia with botulinum toxin a. Int J Neurosci 2022;132(10):1026–1030. https://doi.org/10.1080/00207454.2020.1860039.
Kutvonen O, Dastidar P, Nurmikko T. Pain in spasmodic torticollis. Pain 1997;69(3):279–286. https://doi.org/10.1016/S0304-3959(96)03296-4.
Costanzo M, Belvisi D, Berardelli I, et al. Effect of botulinum toxin on non‐motor symptoms in cervical dystonia. Toxins (Basel). 2021;13(9):647. https://doi.org/10.3390/toxins13090647.
Tinazzi M, Squintani GM, Bhatia KP, Segatti A, Donato F, Valeriani M, Erro R. Pain in cervical dystonia: evidence of abnormal inhibitory control. Parkinsonism Relat Disord 2019;65:252–255. https://doi.org/10.1016/j.parkreldis.2019.06.009.
Wadon ME, Bailey GA, Yilmaz Z, et al. Non‐motor phenotypic subgroups in adult‐onset idiopathic, isolated, focal cervical dystonia. Brain Behav 2021;11(8):e2292. https://doi.org/10.1002/brb3.2292.
Consky E, Lang AE. Clinical assessments of patients with cervical dystonia. In: Jankovic J, Hallett M, eds. Therapy with Botulinum Toxin. New York: Marcel Dekker, Inc.; 1994:211–237.
Comella CL, Perlmutter JS, Jinnah HA, et al. Clinimetric testing of the comprehensive cervical dystonia rating scale. Mov Disord 2016;31(4):563–569. https://doi.org/10.1002/mds.26534.
Bruno V, Achen B, Morgante F, et al. The pain in dystonia scale (PIDS)‐development and validation in cervical dystonia. Mov Disord 2023;38(7):1175–1186. https://doi.org/10.1002/mds.29452.
Listik C, Listik E, de Paiva Santos Rolim F, et al. Development and validation of the dystonia‐pain classification system: a multicenter study. Mov Disord 2023;38(7):1163–1174. https://doi.org/10.1002/mds.29423.
Chinnapongse R, Pappert EJ, Evatt M, Freeman A, Birmingham W. An open‐label, sequential dose‐escalation, safety, and tolerability study of rimabotulinumtoxinb in subjects with cervical dystonia. Int J Neurosci 2010;120(11):703–710. https://doi.org/10.3109/00207454.2010.515047.
Truong D, Brodsky M, Lew M, et al. Long‐term efficacy and safety of botulinum toxin type a (Dysport) in cervical dystonia. Parkinsonism Relat Disord 2010;16(5):316–323. https://doi.org/10.1016/j.parkreldis.2010.03.002.
Sachdev PS, Blacker D, Blazer DG, Ganguli M, Jeste DV, Paulsen JS, Petersen RC. Classifying neurocognitive disorders: the DSM‐5 approach. Nat Rev Neurol 2014;10(11):634–642. https://doi.org/10.1038/nrneurol.2014.181.
Comella CL, Leurgans S, Wuu J, Stebbins GT, Chmura T, The Dystonia Study Group. Rating scales for dystonia: a multicenter assessment. Mov Disord 2003;18(3):303–312.
Muller J. Craniocervical dystonia questionnaire (CDQ‐24): development and validation of a disease‐specific quality of life instrument. J Neurol Neurosurg Psychiatry 2004;75(5):749–753.
Velucci V, Idrissi S, Pellicciari R, et al. Italian dystonia registry participants. Does sex influence the natural history of idiopathic adult‐onset dystonia? J Neurol Neurosurg Psychiatry 2024;95(8):784–790. https://doi.org/10.1136/jnnp-2023-332927.
Fillingim RB. Individual differences in pain: understanding the mosaic that makes pain personal. Pain 2017;158(Suppl 1):S11–S18. https://doi.org/10.1097/j.pain.0000000000000775.
Lumley MA, Cohen JL, Borszcz GS, et al. Pain and emotion: a biopsychosocial review of recent research. J Clin Psychol 2011;67(9):942–968. https://doi.org/10.1002/jclp.20816.
Chawda SJ, Münchau A, Johnson D, et al. Pattern of premature degenerative changes of the cervical spine in patients with spasmodic torticollis and the impact on the outcome of selective peripheral denervation. J Neurol Neurosurg Psychiatry 2000;68(4):465–471. https://doi.org/10.1136/jnnp.68.4.465.
De Pauw J, Van der Velden K, Meirte J, et al. The effectiveness of physiotherapy for cervical dystonia: a systematic literature review. J Neurol 2014;261(10):1857–1865. https://doi.org/10.1007/s00415-013-7220-8.
Loudovici‐Krug D, Derlien S, Best N, Günther A. Physiotherapy for cervical dystonia: a systematic review of randomised controlled trials. Toxins (Basel) 2022;14(11):784. https://doi.org/10.3390/toxins14110784.
Jacksch C, Loens S, Mueller J, Tadic V, Bäumer T, Zeuner KE. Impact of physiotherapy in the treatment of pain in cervical dystonia. Tremor Other Hyperkinet Mov (N Y) 2024;14:11. https://doi.org/10.5334/tohm.867.
McCambridge A, Meiring RM, Bradnam LV. Physical activity, sedentary behavior, and barriers to exercise in people living with dystonia. Front Neurol 2019;10:1121. https://doi.org/10.3389/fneur.2019.01121.
Wadon ME, Fenner E, Kendall KM, Bailey GA, Sandor C, Rees E, Peall KJ. Clinical and genotypic analysis in determining dystonia non‐motor phenotypic heterogeneity: a UK biobank study. J Neurol 2022;269(12):6436–6451. https://doi.org/10.1007/s00415-022-11307-4.
Lobbezoo F, Thu Thon M, Rémillard G, Montplaisir JY, Lavigne GJ. Relationship between sleep, neck muscle activity, and pain in cervical dystonia. Can J Neurol Sci 1996;23(4):285–290. https://doi.org/10.1017/s0317167100038233.
Baune BT, Caniato RN, Garcia‐Alcaraz MA, Berger K. Combined effects of major depression, pain and somatic disorders on general functioning in the general adult population. Pain 2008;138(2):310–317. https://doi.org/10.1016/j.pain.2008.01.002.